These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 56221)

  • 1. C-type virus-associated antigens and their relevance to human leukemia control.
    Aoki T; Sibal LR
    Cancer Res; 1976 Feb; 36(2 pt 2):591-7. PubMed ID: 56221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of different glycosylated antigens in C-type virus-transformed and infected rat cells by antiserum to murine leukemia virus.
    Rieber M; Bacalao J; Rieber M; Alonso G
    Cancer Res; 1977 Apr; 37(4):1165-9. PubMed ID: 191179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential leukemia virus subunit vaccines: discussion.
    Bolognesi DP
    Cancer Res; 1976 Feb; 36(2 pt 2):655-6. PubMed ID: 1253151
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with Simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient.
    Derks JP; Hofmans L; Bruning HW; von Rood JJ
    Cancer Res; 1982 Feb; 42(2):681-6. PubMed ID: 6173117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to immunological control of virus-associated tumors in man: introductory remarks.
    Levine PH
    Cancer Res; 1976 Feb; 36(2 pt 2):565-9. PubMed ID: 175916
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses.
    Ferrer JF
    Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammalian C-type oncorna viruses. Relationships between structural virus and cell surface antigens and their possible significance in immunological defense mechanisms.
    Schäfer W; Claviez M; Frank H; Hunsmann G; Moennig V; Schwarz H; Thiel HJ; Bolognesi DP; Green RW; Langlois AJ; Fischinger PJ; De Noronha F
    Bibl Haematol; 1975 Oct; (43):88-96. PubMed ID: 61006
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluids.
    Herbrink P; Moen JE; Brouwer J; Warnaar SO
    Cancer Res; 1980 Jan; 40(1):166-73. PubMed ID: 6243087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (Mr 30,000).
    Hehlmann R; Schetters H; Erfle V; Leib-Mösch C
    Cancer Res; 1983 Jan; 43(1):392-9. PubMed ID: 6291760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued presence of similar transformation-associated antigens related to murine oncornavirus proteins in -ransformed cells, morphological revertants, and cells restricted in the expression of transformation.
    Rieber M; Bacalao J; Rieber M
    Cancer Res; 1977 Apr; 37(4):1170-4. PubMed ID: 191180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.
    Mathews JH; Roehrig JT
    J Immunol; 1982 Dec; 129(6):2763-7. PubMed ID: 6183343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy in patients with oral malignant disease.
    Perlin E
    Otolaryngol Clin North Am; 1979 Feb; 12(1):195-9. PubMed ID: 440739
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactivity of antisera to oncorna virus proteins with human leukaemia cells.
    Oliver RT; Pillai A
    Proc R Soc Med; 1977 Aug; 70(8):556-9. PubMed ID: 72387
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vitro antibody response to cell surface antigens. II. Monoclonal antibodies to human leukemia cells.
    Levy R; Dilley J
    J Immunol; 1977 Aug; 119(2):394-400. PubMed ID: 301891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30.
    Herbrink P; van Bussel FJ; Warnaar SO
    Anticancer Res; 1982; 2(5):291-6. PubMed ID: 6299171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline virus-induced tumors and the immune response: recent developments.
    Essex M; Cotter SM; Carpenter JL
    Am J Vet Res; 1973 Jun; 34(6):809-12. PubMed ID: 4350543
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of an antigen of the bovine C-type virus.
    McDonald HC; Graves DC; Ferrer JF
    Cancer Res; 1976 Apr; 36(4):1251-7. PubMed ID: 56993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.